Furegrelate sodium

Overview

Furegrelate Sodium (U-63557A) is a potent, orally available, and selective thromboxane synthase inhibitor. Furegrelate Sodium inhibits human platelet microsomal thromboxane A2 (TxA2) synthase with an IC 50 of 15 nM. Furegrelate Sodium is being developed as an antiplatelet agent.

Application

Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Cardiovascular Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Prostaglandin Receptor

Product Information

• Catalog No.: HY-106080A
• CAS No.: 85666-17-7
• Molecular Formula: C15H10NNaO3
• Molecular Weight: 275.23
• Purity: 99.69%
• Storage: -20°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 1.67 mg/mL (6.07 mM); Clear solution
• Availability: In-stock

Source

Original product source